Madeline Figlewski

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages”.

A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages

OncoImmunology(2025)10.1080/2162402x.2025.2543614

N/A

0DataRank · unranked

15 citations

Sarah M. Shin, Jennifer N. Durham, Hanfei Qi, Alexei Hernandez, Erin M. Coyne +19 more

A phase Ib study of a pooled synthetic long peptide mutant KRAS vaccine combined with balstilimab/botensilimab in metastatic pancreatic cancer and metastatic MMR-proficient colorectal cancer in the maintenance setting.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps2698

N/A

0DataRank · unranked

0 citations

Amanda L. Huff, Maureen Berg, Hao Wang, Julie M. Nauroth, Kyle Friedman +7 more